Mortality trends and disparities in older U.S. adults with coexisting chronic obstructive pulmonary disease and Alzheimer’s disease, 1999—2023
- 1Yu Shu, MD, MS Department of Respiratory and Critical Care Medicine, Beijing Bo’ai Hospital, China Rehabilitation Research Center, Capital Medical University, Beijing, China
- 2Feng Yang, MD, MS Department of Respiratory and Critical Care Medicine, Beijing Bo’ai Hospital, China Rehabilitation Research Center, Capital Medical University, Beijing, China
Abstract
Objectives:: Chronic obstructive pulmonary disease (COPD) and Alzheimer’s disease (AD) are leading causes of death among older adults. Their coexistence complicates clinical management and increases disease burden; however, long-term national mortality trends for this comorbidity remain poorly characterized.
Methodology:: We conducted a retrospective analysis at the Department of Respiratory and Critical Care Medicine, Beijing Bo‘ai Hospital, China Rehabilitation Research Center, Capital Medical University, using U.S. mortality data from the CDC WONDER Multiple Cause of Death database (1999–2023) for individuals aged ≥65 years with both COPD (ICD-10: J40–J44) and AD (ICD-10: G30) listed as causes of death. Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated across age, sex, race/ethnicity, census region, and urbanization level.
Results:: From 1999 to 2023, 151,250 deaths were recorded with COPD–AD comorbidity. Age-adjusted mortality rates increased significantly among adults ≥85 years (AAMR: 46.46 to 59.31 per 100,000; average annual percent change [AAPC] = 1.01%). Sex-specific trends diverged: AAMR declined in males (AAPC = −1.06%) but rose in females (AAPC = 1.31%). Geographically, the Northeast experienced a significant decline (AAPC = −1.61%), whereas both metropolitan (AAPC = 1.29%) and nonmetropolitan areas (AAPC = 2.02%) showed increases, with a steeper rise in nonmetropolitan regions.
Conclusion:: Mortality trends for COPD–AD comorbidity among older U.S. adults exhibited substantial demographic and geographic disparities over the 25-year period. These findings underscore the need for targeted public health strategies and further etiologic investigation.
Related
- National trends and demographic disparities in mortality involving co-listed chronic obstructive pulmonary disease and substance use disorders among U.S. adults aged ≥65 years: A population-based serial cross-sectional CDC WONDER analysis, 1999 to 2020
- Cachexia and Sarcopenia in Patients with Coexisting Chronic Obstructive Pulmonary Disease and Pulmonary Tuberculosis
- Development and validation of an interpretable machine learning model for early prediction of mortality in ICU patients with chronic obstructive pulmonary disease and heart failure
- Trends, cross-country inequalities and risk factors in the global burden of chronic obstructive pulmonary disease mortality, 1990-2021: a secondary data analysis of the Global Burden of Disease Study 2021.
- Tracheal Eccentricity is Associated with Respiratory Morbidity and Mortality in Chronic Obstructive Pulmonary Disease
BibTeX
@article{shu2026mortality,
title = {{Mortality trends and disparities in older U.S. adults with coexisting chronic obstructive pulmonary disease and Alzheimer’s disease, 1999—2023}},
author = {Yu Shu and Feng Yang},
journal = {Pakistan Journal of Medical Sciences},
year = {2026},
month = nov,
doi = {10.12669/pjms.42.10.14808},
url = {https://doi.org/10.12669/pjms.42.10.14808},
note = {CC BY 3.0},
}
RIS
TY - JOUR
TI - Mortality trends and disparities in older U.S. adults with coexisting chronic obstructive pulmonary disease and Alzheimer’s disease, 1999—2023
AU - Yu Shu
AU - Feng Yang
PY - 2026
DA - 2026/11/17
JO - Pakistan Journal of Medical Sciences
DO - 10.12669/pjms.42.10.14808
UR - https://doi.org/10.12669/pjms.42.10.14808
AB - Objectives:: Chronic obstructive pulmonary disease (COPD) and Alzheimer’s disease (AD) are leading causes of death among older adults. Their coexistence complicates clinical management and increases disease burden; however, long-term national mortality trends for this comorbidity remain poorly characterized. Methodology:: We conducted a retrospective analysis at the Department of Respiratory and Critical Care Medicine, Beijing Bo‘ai Hospital, China Rehabilitation Research Center, Capital Medical University, using U.S. mortality data from the CDC WONDER Multiple Cause of Death database (1999–2023) for individuals aged ≥65 years with both COPD (ICD-10: J40–J44) and AD (ICD-10: G30) listed as causes of death. Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated across age, sex, race/ethnicity, census region, and urbanization level. Results:: From 1999 to 2023, 151,250 deaths were recorded with COPD–AD comorbidity. Age-adjusted mortality rates increased significantly among adults ≥85 years (AAMR: 46.46 to 59.31 per 100,000; average annual percent change [AAPC] = 1.01%). Sex-specific trends diverged: AAMR declined in males (AAPC = −1.06%) but rose in females (AAPC = 1.31%). Geographically, the Northeast experienced a significant decline (AAPC = −1.61%), whereas both metropolitan (AAPC = 1.29%) and nonmetropolitan areas (AAPC = 2.02%) showed increases, with a steeper rise in nonmetropolitan regions. Conclusion:: Mortality trends for COPD–AD comorbidity among older U.S. adults exhibited substantial demographic and geographic disparities over the 25-year period. These findings underscore the need for targeted public health strategies and further etiologic investigation.
SN - 1682-024X
SN - 1681-715X
ER -